Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8c97610ca3bf3363a9c768da40cbb26 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 |
filingDate |
2020-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2caaa27894117f263daef7b0bdfb553 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3042953f7a5ac75d16a41f10d9b68d23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a0328f47108f093c4c26aa2acd3e717 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abeb090f40975e74f20cb57b0c8317fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adf5e11263605dcbfe5e2fc29c75b480 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d21c0abf50aa697bd76afc2f77cbc4a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f189a26f6ddc72a78457219f4f3d4f16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a17d8e56702343c6e76eab2d55f16eee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8d127db64efbf1e6bdde722206a2206 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d58ebba90993767c5bd2f6b7e221cbda http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d7a40096afe46d152f2bd4c7f4824dd |
publicationDate |
2021-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2020237517-A2 |
titleOfInvention |
Therapeutic agent preparations and methods for drug delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
abstract |
Embodiments of the invention provide swallowable devices, preparations and methods for delivering therapeutic agents (TA) within the GI tract. Many embodiments provide a swallowable device such as a capsule for delivering TAs into the intestinal wall (IW) or other GI location. Embodiments also provide various TA preparations (e.g., insulin or IgG) configured to be contained within the capsule, advanced from the capsule into the IW and degrade to release the TA into the bloodstream where they exhibit a selected plasma concentration profile which may have selected pharmacokinetic parameters. The preparation can be operably coupled to a delivery means having a first configuration where the preparation is contained in the capsule and a second configuration where the preparation is advanced out of the capsule into the IW. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract. |
priorityDate |
2019-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |